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Summary.-The growth of a transplantable lymphoma was examined in normal
mice and in mice previously infected with the lymphoma-inducing virus (ULV).
Normal BALB/c mice respond to a footpad injection of X-irradiated lymphoma cells
ULMC) with popliteal lymph node (PLN) enlargement; mice previously infected
with ULV do not. 106 viable ULMC injected into the footpads of ULV-infected mice
grew progressively, and the animals died with disseminating malignant lymphoma.
In contrast, this dose of cells injected into normal animals evoked strong host re-
sponses in the foot and draining lymph node, and no progressive growth of the
lymphoma occurred. This increased susceptibility of the ULV-infected animals
was also observed when ULMC were injected s.c. into the back or i.m. into the calf
muscle, but not after s.c. injection of an unrelated 3-methylcholanthrene-induced
sarcoma. Resistance to tumour growth after i.v. injection of ULMC is clearly
ineffective, since 10 cells can grow and kill the animal, and in this case no increased
susceptibility of ULV-infected animals was observed.
MICE which have been infected with a
lymphomagenic virus (ULV), originally
isolated from a urethane-induced lym-
phoma (Salaman, 1963), can be shown to
have developed new antigenicity in various
tissues. Grafts of their skin are rejected
by uninfected syngeneic mice, and further-
more, their spleen cells, when injected
into the footpads of uninfected syngeneic
recipients, cause enlargement ofthe drain-
ing popliteal lymph nodes (PLN). No
such responses are evoked in infected mice
which are the recipients of tissues from
either infected or uninfected mice (Sala-
man et al., 1972; Salaman, Turk and
Wedderburn, 1973).
PLN enlargement following footpad
injection of spleen cells taken early in the
preleukaemic phase is not specific for cells
from ULV-infected donors: the sameeffect
occurs when cells from mice infected with
any one of several other leukaemogenic
viruses are used. Similar effects, indi-
cating the development ofnew antigenicity
(" heterogenization ") in donor tissues,
have been described for both oncogenic
and non-oncogenic viruses by several
authors (Breyere and Williams, 1964;
Svet-Moldavsky et al., 1970; Holtermann
and Majde, 1969).
We have already shown that the non-
reactivity of ULV-infected animals is at
least partiallyr specific. While they do not
respond with PLN enlargement to the
footpad injection of spleen cells from
similarly infected mice, they will respond
normally to cells from mice infected with
the lactate-dehydrogenase-elevating virus
of Riley (LDV). The reverse is also true,
in that LDV-infected mice respond to cells
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fromULV-,but not fromLDV-infected ani-
mals (Wedderburn et al., in preparation).
We wished to determine whether this
non-reactivity of ULV-infected animals
towards the prelymphomatous tissues of
syngeneic animals infected with the same
virus, would be paralleled by a decrease in
resistance to the growth of malignant cells
from a ULV-induced lymphoma (ULMC).
We show that there was such a decrease in
resistance in infected, compared with
uninfected, recipients when ULMC were
injected by the s.c. or i.m. route. Infected
anduninfectedmicewere, however, equally
susceptible to the growth of a methyl-
cholanthrene-induced tumour, injected s.c.
MATERIALS AND METHODS
Mice.-Male BALB/c mice 8-12 weeks old
were used; they were never more than 3
generations removed from a single-litter-
mated line.
Virus.-Lymphomatous tissues from mice
inoculated with ULV when newborn were
passed through a sieve, twice centrifuged and
stored at -70°C. Mice were infected by i.v.
injection of 0-1 ml of this virus preparation.
ULV-induced malignant cell line.-The
commonest neoplasm produced by ULV is a
lymphoblastic lymphoma, but a few viral
substrains have produced reticulum cell
neoplasms. On 2 occasions, a disease indis-
tinguishablefromhaemorrhagicFrienddisease
hasdeveloped(cf.Carteretal., 1970). The latent
period of ULV-induced lymphoma in adult-
inoculated BALB/c mice is seldom less than
3 months, and more usually 5-8 months.
The malignant cell line (ULMC) used in the
experiments reported here was established
from the spleen of a BALB/c mouse with a
ULV-induced lymphoblastic lymphoma.
The cells were passed serially by i.v. injection
FIG. 1. Lumbar spine from normal mouse injected i.v. with 103 ULMC. Lymphomatous infiltrates
are seen within the theca, in the vertebral marrow and around paravertebral muscles. (Some
animals showed perivascular infiltrates in the cord itself, but no direct invasion of the cord and no
degenerative changes). H. and E. x 50.
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of suspensions of spleen cells in Ringer's
saline. Suspensions made between the 30th
and 60th passage were used in the present
work. Spleens weighing 600-1200 mg, from
mice injected with ULMC, were used for tests
of the growth of malignant cells, and at this
stage of the disease most nucleated spleen
cells had a diameter at least twice that of a
normal lymphocyte. Only viable (nigrosin-
excluding) cells of this size were counted in
the estimation of cell dose.
Meth A cell line. Sarcoma Meth A,
induced by methylcholanthrene and passed
in BALB/c mice (Old et al., 1962) was received
from Dr L. J. Old.
PLN r-eactivity.-Malignant cells, either
viable or irradiated (6500 rad), were injected
into the footpads of recipients in 0 03 ml of
Ringer's saline (Salaman et al., 1973). PLNs
were excised at various intervals, weighed
and examined histologically.
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Histology.-PLNs and other tissues were
fixed in formol acetic alcohol. Feet and
portions of the lumbar spine were decalcified
in 10% formic acid. Wax-embedded sections
were prepared at 5 ,um, stained with haema-
toxylin and eosin, and also ith methyl green
pyronin.
RESULTS
Growth of ULV-induced malignant cells
(ULMC) injected i.v. into normal mice
All mice injected with 107 ULMC died
about 7 dayslaterwithgross splenomegaly.
Histological examination confirmed the
presence of massive infiltration by malig-
nant lymphoma, obliterating normal
structures in the red and white pulp.
Doses of 106 or 105 ULMC were also
Day s
FIa. 2. Popliteal lymph node weights at various times after the injection of 106 viable ULMC into the
footpads of normal (00- ) and ULV-infected (0 O)mice.
FiG. 3. Footpad, normal mouse, Day 9. Large darklv staining lymphomatous cells, interspersed
with normal lymphocytes and mononuclear cells. Decalcified, H. and E. x 570.
FIG. 4. Footpad, normal mouse, Day 15. Localized cellular infiltrate composed of a few, darkly
staining lymphomatous elements (many ofthem degenerate) and host cells. Decalcified, H. and E.
x 570.
FIG. 5. Footpad, ULV-infected mouse, Day 15. Diffuse growth of lymphomatous cells with few
recognizable host elements. Decalcified, H. and E. x 570.
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TABLE I.-PLN Response of Normal and Infected Mice to Malignant Cells (ULMC)
Injected into the Hind Footpads
Inoculum
107 live ULMC
106 live ULMC
105 live ULMC
107 irradiated ULMC (6500 rad)
Ringer's soln.
* 4 mice/group (8 PLNs) weighed on Day 9.
t 4 weeks before footpad injection.
+ Enlargement (Itue to lymphomatous infiltration.
uniformly fatal. All the animals died
with similar splenic involvement, but with
longer survival times than mice which
received the highest dose of cells.
Sixty to 90%o of mice which received
104, and about 500 of those which
received 1 0-103, ULMC also died, but the
findings in these groups were variable.
In some animals gross splenic involve-
ment developed, though more slowly;
others presented with paralysed hind-legs,
and a few developed hepatomegaly due to
lymphomatous infiltrates. Fig. 1 shows a
section through the spine of a paraplegic
animal. In some of the paralysed mice
the spleen was normal in size and appear-
ance; others had spleens which were only
slightly enlarged, containing 1-3 promi-
nent discrete white foci of malignant cells,
whereas confluent splenic involvement was
invariably seen in the animals which had
received large doses of ULMC.
PLN responses of normal and infected mice
to s.c. injected ULMC
In order to determine whether the
responses of normal and infected mice to
ULMC would be similar to those pre-
viously evoked by injection of prelym-
phomatous spleen cells (Salaman et al.,
1973), groups of 4 normal and 4 infected
mice were injected with 107, 106, or 105
viable ULMC, or 107 X-rayed cells, into
PLN wt. ofrecipient* (mg) ls.d.
f- _ __
Normal ITLV-Tnfectedt
10-5 2-3 4-3t±2-5
5-4±1-2 1-7 -10 5
2-1±0-8 1-7 ±1.0
4 940 9 1 0 ±0 2
1-3- O-2 1-4 -0 3
the footpads. Nine days later, PLNs
were removed and weighed (Table I).
Lymph nodes from ULV-infected animals
showed little enlargement after the in-
jection of 106 or 105 live, or 107 X-rayed,
ULMC. PLN enlargement was, however,
observed in infected mice given 107 live
cells, but histological examination showed
that these nodes were already infiltrated
with lymphoma. Further groups of 20
infected or uninfected mice were injected
with 106 viable ULMC and killed serially.
Fig. 2 shows PLN responses at various
timesafterinjection. Theuninfected mice
showed a considerable increase in PLN
weights on Day 9, which then retuirnied
towards the normal valtue. Infected mice
again showed very little PLN weight
increase on Day 9, but thereafter their
lymph nodes enlarged progressively. In-
fected animals not killed on or before
Day 22 died with gross splenomegaly
before Day 43.
Histological changes evoked by 106 ULMC
injected into normal and infected mice
Morphological changes were examined
at the site of injection (footpad), the
regional lymph nodes and the spleen.
Footpads
Appearances in the feet were similar in
both groups at Day 4, with a modest
FiG. 6. Popliteal lymph node (PLN), normal mouse, Day 9. Nuimerous pyroninophilic blast cells
in the paracortex. Methyl green-pyronin (MGP). x 570.
Frc. 7.-PLN, normal mouse, Day 15. Darkly staining pyronin<ophilic cells accumulating in medul-
lary cords. MGP. x 570.
FIG. 8.-PLN, ULV-infected mouse, Day 9. A negligible number of pyroninophilic paracortical blast
cells. MGP. x 570.
Fic. 9. PLN, ULV-infecte(d mouise, Day 15. Partial replacernent by malignant lymphoma; mitotic
figures numerous. H. and E. x 570.
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growth of leukaemic cells extending round
muscle bundles, and a scanty host-cell
infiltrate composed mainly of small lym-
phocytes and large mononuclear cells.
The appearances in the 2 groups began to
differ after Day 9 (Fig. 3). In normal
mice, the leukaemic infiltrate progressively
declined, while the host-cell component
increased markedly up to Day 15 (Fig. 4);
this subsequently dwindled and the tissues
were normal at Day 60. At all the stages
examined, the host-cell response did not
vary in its composition; polymorphs were
rarely seen and there was no granuloma
formation.
In infected mice, the leukaemic cells
grew progressively. The scanty round-
cell infiltrate, present on Day 4, did not
develop further and, after Day 15 (Fig. 5),
was obscured by leukaemic elements.
Leukaemic cells extended widely in the
soft tissues of the feet and, in some
animals, invaded local bone and marrow
spaces.
Popliteal lymiph nodes
Morphological changes in the regional
lymph node were similar in both groups at
Day 4, with a slight increase inthe numbers
of pyroninophilic cells in the paracortex.
The medullary cords and follicles were
quiescent. The responses again diverged
in the two groups at Day 9. In normal
mice, the paracortical reaction was marked
at this time (Fig. 6); it then slowly
declined and pyroninophilic cells became
prominent in the medullary cords and, to
a lesser extent, the follicles (Fig. 7). No
leukaemic involvement was seen at any
stage. The nodes were histologically in-
active at Day 60.
In infected mice, the initial paracortical
response was not maintained (Fig. 8) and
no reactive changes developed in the
medullary cords and follicles. Sheets of
infiltrating leukaemic cells were noted at
Day 15 (Fig. 9), replacing the local nodes
by Day 22.
Spleens
In normal mice, appearances in the
splenic red and white pulp remained
unchanged. Definite reactive changes
were observed in the spleens of ULV-
infected mice, both in the groups injected
with ULMC and a similar group which
received Ringer's solution only. In in
fected mice which received ULMC in the
footpads, these changes did not evolve
during the course of the experiment,
and they persisted until they were oblite-
rated by leukaemic deposits on and after
Day 15.
The effect of varyiny the route of admini-
stration, and the cell dose, on the growth of
ULMC in infected and normal mice.
ULMC were injected either s.c. into the
back or the footpad, or i.m. into the calf
muscles. The proportions of mice in
which tumours grew progressively are
shown in Table II. Mice which developed
large tumours usually also developed gross
splenomegaly before death. Normal mice
injected i.m. with 106 ULMC showed
considerable local enlargement in the leg,
maximal on Day 10. This eventually
subsided, and 5 weeks after inoculation of
ULMC there was no evidence of tumour
growth. When ULMC were injected s.c.,
the dose which would grow progressively
in infected mice was 10-100-fold less than
that needed to produce the same effect in
normal mice. When 105 cells were in-
jected s.c. they did not grow in either
group, in contrast to i.v.-administered
cells.
Effect of ULV infection on the PLN
response to X-rayed Meth A cells and the
growth of live Meth A cells
In order to determine whether ULV-
infected animals would be more suscep-
tible than normal mice to the s.c. injection
of cells from an unrelated tumour, the
responses of the 2 groups to a 3-methyl-
cholanthrene-induced sarcoma were de-
termined. When X-rayed Meth A cells
were injected into normal and ULV
infected animals, they produced the same
degree ofPLN enlargement inboth groups,
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TABLE II. Growth of ULMC in Normal and ULV-infected Mice
Site of
injection Inoculum
s.c. back ]07 live ULMC
106 live ULMC
105 live ULMC
s.c. into each 107 live ULMC
hind footpad 106 live ULMC
105 live ULMC
i.m. calf 106 live ULMC
0O Recipients showing progressive growth
Normal ULV-infected*
20 (5/25)t 89 (16/18)
0 (0/12) 83 (10/12)
0 (0/12) 0 (0/12)
0 (0/6) 100 (6/6)
0 (0/6) 100 (6/6)
0 (0/6) 0 (0/6)
0 (0/6) 100 (6/6)
* ULV i.v. 4 weeks previously.
number of mice which developed tumours
t Fn total number of mice injected
TABLE III.--Growth ofMeth A Cells in Normal and ULV-Infected Mice: PLAT Responses
to X-irradiated (6500 rad) Meth A and ULMC
Inoculum
and site
104 live Meth A
cells, s.c. back
103 live Meth A
cells, s.c. back
107 irradiated ULMC,
hind footpads
2 x 106 irradiated
Meth A cells, hind
footpads
Normal recipients ULV-infected recipients
PLN wt. (mg)+s.d. Tumours PLN wt. (mg) s.d. Tumoturs
6/8
3/8
6-1 1-10
4-5 1*0
6/8
4/7
1 34-0 4
4-714*4
while X-rayed ULMC cells produced the
expected difference in PLN weights
between the groups. When live Meth A
cells were injected s.c. there was no
significant difference between the groups
in the number ofmice developing tumours,
the time at which such tumours first
appeared, orthe rate ofgrowth (Table III).
Effect of injecting ULMC i.v. into ULV-
infected, and normal mice
It was clear from preliminary experi-
ments that the interaction between the
growth of ULMC and the development of
an immune response to these cells differed
according to the route of administration.
After i.v. injection, the number of animals
TABLE IV.-Growth of Various Doses of i.v.-injected ULMC in Normal and ULV-
infected Mice
No. of
7)
8
4)
6~
Normal recipients
-A )
f deaths MSTt (days)
'/7 7 0
(7)
/8 12-8
(12-14)
/10 19 - 5
(18-21)
/10 23-7
(19-27)
ULV-infected recipients*
No. of deaths MST (days)
6/7 14- 3
(7-27)
4/10
3/10
19-5
(12-41)
21 -8
(17-27)
39 7
(21-56)
* ULV i.v. 4 weeks previously.
t MST = Mean Survival Time. Range in parentheses.
Inoculum
107 ULMC
105 ULMC
103 ULMC
10 ULMC
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which died was almost independent of cell
dose: 10 cells grew and caused the death of
about half the animals, in contrast to the
effect of s.c. inoculation, where much
larger doses were necessary for progressive
growth. When the effect of i.v. ULMC
was compared in normal and infected
mice, it was shown that there was some
lengthening of the mean survival time in
infected as compared to normal animals.
This took the form of an increased range
of survival times in the former group, the
first animals succumbing at about the
same time as the controls. The numbers
of animals dying were not significantly
different in the two groups.
DISCUSSION
Xte have been interested in the
possibility that the induction of altered
antigenicity in various tissues of virus-
in.fected animals might be related to the
progressive growth or rejection of trans-
plants of a tumour originally induced by
the same virus.
Situations in which such new anti-
genicity, or "heterogenization ", has been
demonstrated in animals which are either
tumour-bearing, virus-infected, or both,
can be divided into at least 2 categories.
Mariani and her colleagues (reviewed by
Mariani and Good, 1973) have produced
considerable evidence that rejection of
skin from tumour-bearing donors is re-
lated to the presence of a small number of
tumour cells in the graft. In their
opinion the rejection is " not of immuno-
logic origin ": the course of rejection is
unaltered by prior administration of 400R
of whole-body irradiation to the recipients
(Mariani, Maruyama and Good, 1972).
On the other hand, viruses such as lympho-
cytic choriomeningitis virus (1CM)
(Holtermann and Majde, 1969), or the
skin-heterogenizing virus (SHV) described
by Svet-Moldavsky and his colleagues
(Svet-Moldavsky et al., 1970) appeared to
have heterogenizing, without oncogenic,
potential. In the case of SHV the pro-
portion of virus-infected skin grafts re-
jected was reduced by prior administration
of 400R to the recipients, and the survival
time of those which were rejected was
lengthened (Liozner, Svet-Moldavsky and
Mkheidze, 1970).
Recent work by several groups
(Zinkernagel and Doherty, 1974; Koszi-
nowski and Ertl, 1975; Garrido, Schirr-
macher and Festenstein, 1976) suggests
that such viral heterogenization may be a
manifestation, either of alteration of anti-
gens closely linked to histocompatilility
antigens, or ofthe expression of such anti-
gens themselves. In our own system, no
tumours grew at the sites ofeither accepted
or rejected skin grafts, nor were tumour
cells seen in sections of the graft bed
(Salaman et al., 1972), although mice were
watched for at least 6 months. We also
observed that mice which had been
infected with ULV were in all cases unable
to reject heterogenized syngeneic grafts.
Far from there being a second-set type of
rejection by previously uninfected recipi-
ents which had rejected a first hetero-
genized graft, a second graft was often
accepted (Salaman et al., 1972). Our
observation of PLN responses following
injection of spleen cells from infected
animals into the footpads of normal
animals has given analogous results:
significant enlargement occurs in normal,
but not in infected recipients, which
become non-reactive within 4-8 days of
infection (Salaman et al., 1973).
WVe show here that ULV-infected mice
also failed to react by PLN enlargement
to the injection into the footpads of X-
rayed malignant cells induced by the
infecting virus (Table I). The possi-
bility that this non-reactivity might be
accompanied by decreased resistance to
the growth ofsuch malignant cells was also
investigated. When ULMC were injected
i.m. or s.c., there was a 10-100-fold
difference in the minimum cell number
for progressive growth, the virus-infected
animalsbeingthemoresusceptible. More-
over, histological examination showed that
at the time of maximum activity in the
T-cell-dependent paracortical zones of the
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PLNs in normal recipients (Day 9), there
was very little activity in infected recipi-
ents. Malignant growth in the feet of the
latter was already in advance ofthat in the
former at this time, and by 15 and 22 days
was clearly progressing, and eventually
killed the animals by systemic spread. In
the normal animals, which had shown a
marked PLN reaction, tumours in the feet
regressed, and all mice survived.
The question arose whether the above
effect might be at least partly due to non-
specific immune depression, although ULV
is not strongly immunodepressive during
the preleukaemic period (Wedderburn,
1969). The results using the Metlh A
sarcoma, which indicated that ULV-
infected animals responded by PLN en-
largement to footpad injection of X-rayed
Meth A cells, and did not show increased
susceptibility to the growth oflive Meth A
cells injected s.c., make this explanation
unlikely.
On the other hand, the effect of
previous ULV infection on the growth of
i.v. injected ULMC was to lengthen the
mean survival time. However, the
number of uninfected mice which die from
tumour injected by this route is virtually
independent of cell dose over a wide range,
although the latent period is dose depen-
dent; thus following i.v. injection of
ULMC the immune response seems to be
almost ineffectual as far as protection
against malignant cell growth is concerned.
It seems likely that these results may
be only a part of a complicated interaction
between virus infection and malignant
growth. S.c., as opposed to i.v. injection
of ULV can give fairly effective immuni-
zation against both s.c.- and i.v.-injected
ULMC (Wedderburn et al., in preparation;
cf. Larson et al., 1973). The inter-relation-
ships of the phenomena described here,
and the effects of a variety of immunizing
procedures upon them, are the subject of
further investigation.
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